
Nihon Kohden Corporation
6849.TJPXHealthcareMedical - Devices
Latest quote
¥1,517
+¥11.00 · +0.73%
6849.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteNihon Kohden Corporation, founded in 1951 and headquartered in Tokyo, Japan, is a global leader in healthcare technology. The company’s core operations encompass the research, development, manufacturing, sales, repair, and maintenance of advanced medical electronic equipment, serving markets across Japan, the Americas, Europe, Asia, and other international regions. Its extensive product range features sophisticated physiological measurement instruments, including electroencephalographs (EEGs), electrocardiographs (ECGs), evoked potential and electromyogram (EMG) systems, and polygraphs for cardiac catheterization laboratories. These offerings are integrated with diagnostic information systems and supported by essential consumables like recording papers, electrodes, and catheters, along with comprehensive maintenance services. Nihon Kohden also delivers cutting-edge patient monitoring solutions, such as central, bedside, and wireless monitors, alongside remote access software. These are seamlessly linked with clinical information systems and provided with associated disposables, including various electrodes and sensors. The company's therapeutic device portfolio includes critical equipment like defibrillators (including automated external defibrillators or AEDs), ventilators, pacemakers, anesthesia machines, and cochlear implants. Necessary consumables, such as AED pads and batteries, and related services are also supplied for these products. Furthermore, Nihon Kohden offers other specialized medical apparatus, such as hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and tools for research purposes. These are accompanied by consumables like test reagents, installation services, and ongoing maintenance. Beyond its primary focus on medical devices, the corporation also participates in insurance brokerage and technology licensing.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Hirokazu Ogino
- Listed since
- Jan 1, 2001
- Employees
- 6,116
Market position
Day range
Current ¥1,517
52-week range
Current ¥1,517
- Open
- ¥1,509.5
- Previous close
- ¥1,506
- Volume
- 555K
- 0.82× average
- Average volume
- 676.01K
- Average daily volume
- Market cap
- 242.68B JPY
- Beta
- 0.37
- Market reference 1
- 50-day average
- ¥1,487.6
- +1.98% above average
- 200-day average
- ¥1,561.64
- -2.86% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 226.1B JPY
- P/E (TTM)
- 18.13×
- P/B (TTM)
- 1.37×
- P/S (TTM)
- 1.04×
- EV / EBITDA
- 8.66×
- Earnings yield
- 6.13%
- Free cash flow yield
- 6.48%
- Dividend yield
- 2.11%
Profitability & efficiency
- Gross margin
- 51.29%
- Operating margin
- 6.34%
- Net margin
- 5.86%
- Return on equity
- 8.08%
- Return on assets
- 5.66%
- Return on invested capital
- 6.54%
Financial health
- Debt / equity
- 0.14×
- Current ratio
- 3.6×
- Altman Z-score
- 4.86
- Piotroski F-score
- 7 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 235.1B JPY | 225.42B JPY | 221.99B JPY | 206.6B JPY | 205.13B JPY |
| Cost of goods sold | 117.1B JPY | 111.13B JPY | 113.42B JPY | 103.34B JPY | 98.4B JPY |
| Gross profit | 118B JPY | 114.3B JPY | 108.57B JPY | 103.27B JPY | 106.73B JPY |
| Research and development | 7.45B JPY | 6.83B JPY | 7B JPY | 6.2B JPY | 5.71B JPY |
| Selling, general, and administrative | 91.76B JPY | 86.76B JPY | 81.98B JPY | 75.94B JPY | 70.02B JPY |
| Operating expenses | 99.21B JPY | 93.58B JPY | 88.98B JPY | 82.14B JPY | 75.74B JPY |
| Interest income | 304M JPY | 428M JPY | 289M JPY | 194M JPY | 132M JPY |
| Interest expense | 341M JPY | 144M JPY | 24M JPY | 10M JPY | 11M JPY |
| Depreciation and amortization | 5.82B JPY | 4.19B JPY | 3.85B JPY | 3.79B JPY | 3.49B JPY |
| Operating income | 18.78B JPY | 20.71B JPY | 19.59B JPY | 21.12B JPY | 30.99B JPY |
| Net income | 14.51B JPY | 14.1B JPY | 17.03B JPY | 17.11B JPY | 23.44B JPY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 45%
- 5 beats, 6 misses, 0 met estimates
- Average EPS surprise
- -41.33%
- 11 comparable reports
- Latest EPS result
- -4.6
- Estimate 1.88 · Miss by 344.71%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
¥32.00
2025 complete year+12.3% since 2021
2026 partial: ¥16.00
¥28.50
2,021
¥34.00
2,022
¥35.50
2,023
¥30.50
2,024
¥32.00
2,025
¥16.00
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥16.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥17.00Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥16.00Semi-Annual | Mar 31, 2026 | Jun 26, 2026 |
Dividend | Sep 29, 2025 | ¥16.00Semi-Annual | Sep 30, 2025 | Dec 1, 2025 |
Dividend | Mar 28, 2025 | ¥16.00Semi-Annual | Mar 31, 2025 | Jun 27, 2025 |
Dividend | Sep 27, 2024 | ¥15.00Semi-Annual | Sep 30, 2024 | Nov 27, 2024 |
Ex-dividend Sep 29, 2026
¥16.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥17.00
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥16.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 26, 2026
Ex-dividend Sep 29, 2025
¥16.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 1, 2025
Ex-dividend Mar 28, 2025
¥16.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 27, 2025
Ex-dividend Sep 27, 2024
¥15.00
Semi-Annual
Record Sep 30, 2024 · Payment Nov 27, 2024
6849.T peers
ETFs holding 6849.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T627.1M0.02%2.89T JPY0.05%¥417.8-0.05%
iShares JPX-Nikkei 400 ETF1364.T183.88M0.03%592.34B JPY0.05%¥3,7610.00%
Vanguard Total International Stock ETFVXUS22.79M0.00%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA15.18M0.00%315B USD0.03%$73.42+0.80%
iShares Core MSCI EAFE ETFIEFA11.44M0.01%195.14B USD0.07%$100.85+0.86%
First Eagle Overseas Equity ETFFEOE8.16M0.45%1.71B USD0.79%$56.68+0.85%
iShares MSCI EAFE Small-Cap ETFSCZ5.12M0.04%13.28B USD0.40%$86.60+0.70%
Schwab International Equity ETFSCHF3.77M0.01%69.7B USD0.03%$28.46+0.85%
iShares Core TOPIX ETF1475.T- Market value
- 627.1M
- Weight
- 0.02%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥417.8-0.05%
iShares JPX-Nikkei 400 ETF1364.T- Market value
- 183.88M
- Weight
- 0.03%
- AUM
- 592.34B JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥3,7610.00%
Vanguard Total International Stock ETFVXUS- Market value
- 22.79M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 15.18M
- Weight
- 0.00%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.42+0.80%
iShares Core MSCI EAFE ETFIEFA- Market value
- 11.44M
- Weight
- 0.01%
- AUM
- 195.14B USD
- Expense ratio
- 0.07%
- Price / 1D
- $100.85+0.86%
First Eagle Overseas Equity ETFFEOE- Market value
- 8.16M
- Weight
- 0.45%
- AUM
- 1.71B USD
- Expense ratio
- 0.79%
- Price / 1D
- $56.68+0.85%
iShares MSCI EAFE Small-Cap ETFSCZ- Market value
- 5.12M
- Weight
- 0.04%
- AUM
- 13.28B USD
- Expense ratio
- 0.40%
- Price / 1D
- $86.60+0.70%
Schwab International Equity ETFSCHF- Market value
- 3.77M
- Weight
- 0.01%
- AUM
- 69.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $28.46+0.85%
Continue in GoAI
Research 6849.Tresearch.disclaimer





